Intense light therapy may lower risk of myocardial injuries after non-cardiac surgery
Peer-Reviewed Publication
In recognition of Heart Health Month, we’re spotlighting the importance of cardiovascular wellness. From risk factors and prevention to innovative treatments, we’re exploring the science and stories shaping heart health today.
Updates every hour. Last Updated: 4-Sep-2025 17:11 ET (4-Sep-2025 21:11 GMT/UTC)
Intense light therapy after surgery can increase a critical protein that protects heart tissue while lowering levels of troponin, a protein indicating heart damage that’s linked to higher mortality in patients undergoing non-cardiac surgery, according to a study by researchers at CU Anschutz.
Patients with atrial fibrillation who live in neighborhoods with poor access to grocery stores face sharply higher odds of stroke and death, according to a new study from Tulane University. Compared with similar patients in better-served areas, those in food deserts had more than double the risk of ischemic stroke and nearly four times the risk of death.
OKLAHOMA CITY – A University of Oklahoma study published Sept. 3 in JAMA Surgery reports that acute normovolemic hemodilution (ANH) – a blood-saving method in which a patient’s blood is collected before going on heart-lung bypass and reinfused near the end of cardiac surgery – remains underused in the United States at 14.7%. Yet the study found that ANH lowered the likelihood of a transfusion by 27%, a decrease in blood use that could cut costs substantially while still protecting patient safety and outcomes.
A new study from the University of Sydney has revealed how type 2 diabetes directly alters the heart’s structure and energy systems, offering vital insights into why people with diabetes are at greater risk of heart failure.